from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3456c/rplQ

LFCtreatmentdescriptionclass of inhibitor

-1.474

Amikacinug/mL Amikacintranslation

-0.383

Cap5-10ug/mL Capreomycintranslation

-0.818

Rox10-50 ug/mL Roxithromycintranslation

0.677

SM2-5 ug/mL Streptomycintranslation

-0.538

Tet5-10 ug/mL Tetracyclinetranslation

-1.143

Rif0.2-5ug/mL Rifampicintranscription

-0.819

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.724

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.456

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.184

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.298

Clofazimine10-13 ug/mL Clofaziminerespiration

0.114

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.206

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.007

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.439

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.166

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.295

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.653

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.694

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.031

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.287

KCN5-20 ug/mL Potassium cyaniderespiration

-0.666

NaN30.2-2 mM Sodium aziderespiration

0.697

Nigericin50 uM Nigericinrespiration

-1.815

TRC10-150 ug/mL Triclosanrespiration

-0.833

TRZ10-25 ug/mL Thioridazinerespiration

1.621

Valinomycin0.5-10 uM Valinomycinrespiration

0.651

ZnSO42 mM ZnSO4respiration

0.161

menadione6-10 ug/mL Menadionerespiration

0.205

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.796

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.718

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.813

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.800

NRP_1Non-replicating persistence stage 1dosRassociated

0.999

Amp0.2mg/mL AmpicillincellWall

0.899

Cephalexin20-100 ug/mL CephalexincellWall

0.554

Cerulenin0.32-5 ug/mL CerulenincellWall

0.644

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.216

EMB10-20 ug/mL EthambutolcellWall

-0.258

Eta12-40 ug/mL EthionamidecellWall

0.184

INH0.2-0.4 ug/mL IsoniazidcellWall

0.028

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.351

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.859

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.251

BZA0.12 mg/mL BenzamidearomaticAmides

0.068

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.081

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.022

H2O24 mM hydrogen peroxideDNAdamaging

0.682

Levo10 ug/mL LevofloxacinDNAdamaging

0.903

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.655

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.648

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.182

UVUV-irradiationDNAdamaging

1.224

ARP41-4 ug/mL Antitubercular compound ARP4?

0.447

Antimycin12.5-50 ug/mL Antimycin A?

0.987

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.736

PA_110-50 ug/mL Antitubercular compound PA-1?

0.613

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.674

PA8240.2-2 ug/mL PA-824?

-0.382

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.762

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.972

Verapamil50 uM Verapamil?

0.792

mercaptoethanol2 mM 2-Mercaptoethanol?

0.774

methoxatin10-20 ug/mL Methoxatin?